Leap Therapeutics Earnings Estimate

LPTX Stock  USD 2.79  0.11  3.79%   
By analyzing Leap Therapeutics' earnings estimates, investors can diagnose different trends across Leap Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Leap Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Leap Therapeutics is projected to generate -0.4575 in earnings per share on the 31st of December 2024. Leap Therapeutics earnings estimates show analyst consensus about projected Leap Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Leap Therapeutics' historical volatility. Many public companies, such as Leap Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Leap Therapeutics' earnings estimates, investors can diagnose different trends across Leap Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about (405.6 K) in 2024. Pretax Profit Margin is likely to drop to -32.69 in 2024
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.

Leap Therapeutics Earnings per Share Projection vs Actual

About Leap Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Leap Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Leap Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Leap Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-399.6 M-379.6 M
Retained Earnings Total Equity-237.2 M-249.1 M
Earnings Yield(0.96)(1.01)
Price Earnings Ratio(1.04)(1.09)
Price Earnings To Growth Ratio 0.06  0.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Leap Stock Analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.